Analysis of Airway Responses in Severe COPD Patients to Daxas Using CT Based Functional Respiratory Imaging.
Phase of Trial: Phase IV
Latest Information Update: 02 May 2014
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors FLUIDDA
- 20 Nov 2012 Planned end date changed from 1 Nov 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov.
- 20 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 29 Sep 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2011-004271-36).